The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
Forbes McKenzie, CEO of McKenzie Intelligence Services, explores investments in Britain’s satellite intelligence, strategically focusing on our core strengths.
Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.
In two previous pieces from the October 2021 and January 2022 issues of Open Access Government, we have elaborated on how to extend the ATTRACT experiment into a sustainable tool for accelerating breakthrough innovation across Europe.
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
Recent years have seen an increase in techniques developed for spatial transcriptomics, enabling gene expression patterns to be uncovered within intact, three-dimensional tissues.
The UK will no longer run the REACT study, an 150,000 person analysis of real-time infection, or fund the SIREN study - which monitors COVID levels in healthcare workers.
Kensuke Harada from Graduate School of Engineering Science, Osaka University, provides an introduction to and analysis of a move towards artificial intelligence (AI)-based technology in industrial robots.
The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia – as seen in their lower rates of the disease.
Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.
The REEFCADE long-term research project, created and driven by Professor Rossana Martini, started in 2007 and has since been supported by the Swiss National Science Foundation (SNSF).
Recognising the complex, closely intertwined relationships between humans and nature can lead to better, more cost-effective decisions, outlines Susan Canney, Director of the Mali Elephant Project.
